VOLUME
61 2000 NUMBER 11
Brainstorms
813 The New Cholinesterase Inhibitors for Alzheimer's Disease,
Part 2: Illustrating Their Mechanisms of Action. Stephen M.
Stahl
[PDF]
Original Articles
815 Adverse Neuropsychiatric Reactions to Herbal and
Over-the-Counter "Antidepressants." Ronald Pies
[Abstract]
[PDF]
821 Treatment of Dysthymia With Sertraline: A Double-Blind,
Placebo-Controlled Trial in Dysthymic Patients Without Major
Depression. Arun V. Ravindran, Julien D. Guelfi, Roger M.
Lane, and Giovanni B. Cassano
[Abstract]
[PDF]
828 Paroxetine Levels in Postpartum Depressed Women, Breast
Milk, and Infant Serum. Shaila Misri, John Kim, K. Wayne
Riggs, and Xanthoula Kostaras
[Abstract]
[PDF]
833 Strategies for Switching From Conventional Antipsychotic
Drugs or Risperidone to Olanzapine. Bruce J. Kinon, Bruce R.
Basson, Julie A. Gilmore, Sandra Malcolm, and Virginia L.
Stauffer
[Abstract]
[PDF]
841 A Double-Blind, Placebo-Controlled, Prophylaxis Study of
Lamotrigine in Rapid-Cycling Bipolar Disorder. Joseph R.
Calabrese, Trisha Suppes, Charles L. Bowden, Gary S. Sachs, Alan
C. Swann, Susan L. McElroy, Vivek Kusumakar, John A. Ascher,
Nancy L. Earl, Paul L. Greene, and Eileen T. Monaghan, for the
Lamictal 614 Study Group
[Abstract]
[PDF]
851 The Efficacy and Safety of a New Enteric-Coated
Formulation of Fluoxetine Given Once Weekly During the
Continuation Treatment of Major Depressive Disorder. Mark E.
Schmidt, Maurizio Fava, James M. Robinson, and Rajinder Judge
[Abstract]
[PDF]
858 Bupropion SR Reduces Periodic Limb Movements Associated
With Arousals From Sleep in Depressed Patients With Periodic Limb
Movement Disorder. Eric A. Nofzinger, Amy Fasiczka, Susan
Berman, and Michael E. Thase
[Abstract]
[PDF]
863 Fluoxetine Versus Sertraline and Paroxetine in Major
Depressive Disorder: Changes in Weight With Long-Term Treatment. Maurizio
Fava, Rajinder Judge, Sharon L. Hoog, Mary E. Nilsson, and
Stephanie C. Koke
[Abstract]
[PDF]
868 Schizophrenia-Associated Idiopathic Unconjugated
Hyperbilirubinemia (Gilbert's Syndrome). Tsuyoshi Miyaoka,
Haruo Seno, Motoi Itoga, Masaaki Iijima, Takuji Inagaki,and Jun
Horiguchi
[Abstract]
[PDF]
CME Article 879
880 Differences in Quality of Life Domains and
Psychopathologic and Psychosocial Factors in Psychiatric
Patients. Michael Ritsner, Ilan Modai, Jean Endicott, Olga
Rivkin, Yakov Nechamkin, Peretz Barak, Vladimir Goldin, and
Alexander Ponizovsky
[Abstract]
[PDF]
Letters to the Editor
872 Reboxetine Treatment of Depression in Parkinson's Disease.
Matthias R. Lemke
[PDF]
872 Olanzapine-Induced Neutropenia in Patients With History of
Clozapine Treatment: Two Case Reports From a State Psychiatric
Institution. Christian J. Teter, John J. Early, and Richard J.
Frachtling
[PDF]
873 Venlafaxine Versus Sertraline for Major Depressive
Disorder. Thomas N. Wise and Michael J. Sheridan
[PDF]
874 Adverse Events of Fluoxetine: Postmarketing Compared With
Premarketing Clinical Trials. Mahmoud N. Musa and James M.
Staneluis
[PDF]
874 Diagnosing Melancholia. Iwona Chelminski, Mark
Zimmerman, and Jill I. Mattia
[PDF]
Book reviews 876
Information for Authors
see July 2000, pages 542544 or our Web site at www.psychiatrist.com/author.htm